Cannabis Science & Health
Basic Research and the Mechanism of Action of Ketamine
Dr Stephen Wright, a consultant in medicines development from Limber Strategic, explores the research behind ketamine.
In Arkansas, Four Cannabis Companies Are Accused of THC Inflation
Three cannabis cultivation companies and one testing lab are facing a class action lawsuit in Arkansas. The allegation? That all four conspired to defraud medical cannabis patients by inflating cannabis potency testing results.
AOAC Opens Call For Cannabis Pesticide Testing Methods
Any cannabis lab analyst that has a unique method for identifying and quantifying pesticides in dried cannabis samples has been invited to submit their technique to AOAC International.
Just One-in-Four CBD Topical Products in the US Are Accurately Labeled, Study Finds
As a result of their findings, the Johns Hopkins Medicine researchers say that improvements need to be made to the regulatory oversight of these products in order to ensure good product quality and prevent unwanted drug effects.
Green Scientific Labs Adopts LIMS Software
Green Scientific Labs, the multi-state cannabis testing company, has adopted a new laboratory information management system (LIMS) for immediate use across all its labs.
SC Labs Discusses Lab Shopping and Inter-State Expansions
SC Labs is expanding. The Californian cannabis testing lab moved into Michigan and Colorado this year. How is it braving new frontiers when other labs are struggling with the one location? We asked the company’s new CEO, Jeff Journey, and co-founder Josh Wurzer to find out.
The App That Can Diagnose Sick Cannabis Plants
To learn more about the app that can diagnose cannabis ailments and discuss what technology advancements like this could mean for cultivators, Analytical Cannabis recently caught up with GrowDoc’s founder and CEO, Daniel Lirette.
Microdosing Cannabis Extract Shows “Encouraging” Results in Patient with Alzheimer’s Disease
A 75-year-old man with Alzheimer’s disease is successfully managing his symptoms with microdoses of cannabis, according to a new case report published in the Journal of Medical Case Reports.
First Trial of Transdermal CBD for Adult Epilepsy Reports Mixed Results
To confirm the findings, the researchers say that additional randomized controlled trials on transdermal CBD for adult focal epilepsy are warranted.
